Here you can find all scientific publications about LAKANA and its substudies

• Luoma J, Haidara FC, Samake O, Adubra L, Abdou M, Alber D, Ashorn U, Cloutman-Green E, Diallo M, Juma J, Ducker C, Fan YM, Gruffudd G, Hallamaa L, Ihamuotila R, Martell O, Okello C, Haapaniemi T, Vehmasto T, Murugesan A, Traore CAT, Ylikruuvi K, Klein N, Ashorn P, Sow S, Cheung YB. Development and evaluation of a subjective measurement of geographical hardness-to-reach: a survey of data collectors in a large-scale cluster randomized trial of azithromycin mass drug distribution [version 1]. VeriXiv 2026, 3:55. doi: 10.12688/verixiv.2819.1. [LAKANA Hardness-to-reach substudy]

• Juma J, Luoma J, Traore A, Sangare A, Bouare O, Haidara FC, Samaké O, Adubra L, Ihamuotila R, Martell O, Haapaniemi T, Ylikruuvi K, Ducker C, Ashorn U, Sow S, Ashorn P, Cheung YB, Klein N, Cloutman-Green E, Fan YM, Alber DG. Impact of Azithromycin Administration on Antimicrobial Resistance in the LAKANA Trial in Mali ­- A Cluster-Randomized Controlled Trial [version 1]. VeriXiv 2026, 3:23. doi: 10.12688/verixiv.2661.1. [LAKANA AMR substudy]

• Ihamuotila R, Traoré A, Haidara F, Samaké O, Luoma J, Juma J, Adubra L, Hallamaa L, Cheung YB, Alber D, Ducker C, Ashorn U, Klein N, Ashorn P, Sow S, Fan YM. Effect of a Single Dose of Azithromycin on Environmental Enteric Dysfunction in Infants – A Cluster Randomized Placebo-Controlled Trial [version 1]. VeriXiv 2025, 2:408. doi: 10.12688/verixiv.2494.1. [LAKANA Mechanistic substudy]

• Adubra L, Luoma J, Fan YM, Haidara FC, Samaké O, Ihamuotila R, Ylikruuvi K, Hallamaa L, Martell O, Klein N, Ducker C, Alber D, Ashorn P, Cheung YB, Sow S, Ashorn U. Infant Growth Following Mass Administration of Azithromycin in Mali: A Cluster-Randomized Trial [version 1]. VeriXiv 2025, 2:381. doi: 10.12688/verixiv.2335.1. [LAKANA Growth substudy]

• Haidara FC, Adubra L, Abdou M, Alber D, Ashorn U, Cheung YB, Cloutman-Green E, Diallo M, Ducker C, Fan YM, Gruffudd G, Hallamaa L, Haapaniemi T, Ihamuotila R, Juma J, Klein N, Luoma J, Martell O, Murugesan A, Okello C, Samaké O, Traore CAT, Vehmasto T, Ylikruuvi K, Sow S, Ashorn P. Mass Administration of Azithromycin to Infants in Mali to Reduce Mortality. N Engl J Med. 2025 Oct 16;393(15):1498-1508. doi: 10.1056/NEJMoa2504644.

• Luoma J, Adubra L, Alber D, Ashorn P, Ashorn U, Cloutman-Green E, Diallo F, Ducker C, Elovainio R, Fan YM, Gates L, Gruffudd G, Haapaniemi T, Haidara F, Hallamaa L, Ihamuotila R, Klein N, Martell O, Sow S, Vehmasto T, Cheung YB. Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali. Trials. 2023 Nov 15;24(1):733. doi: 10.1186/s13063-023-07771-6.

• Adubra L, Alber D, Ashorn P, Ashorn U, Cheung YB, Cloutman-Green E, Diallo F, Ducker C, Elovainio R, Fan YM, Gates L, Gruffudd G, Haapaniemi T, Haidara F, Hallamaa L, Ihamuotila R, Klein N, Luoma J, Martell O, Sow S, Vehmasto T; LAKANA Trial Team. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial. Trials. 2023 Jan 3;24(1):5. doi: 10.1186/s13063-022-06966-7.

• Alber D, Haidara FC, Luoma J, Adubra L, Ashorn P, Ashorn U, Badji H, Cloutman-Green E, Diallo F, Ihamuotila R, Klein N, Martell O, Onwuckhekwa UU, Samaké O, Sow SO, Traore A, Wilson K, Ducker C, Fan YM. SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021. BMJ Open. 2022 Jun 16;12(6):e060367. doi: 10.1136/bmjopen-2021-060367. [LAKANA-COVID substudy]